Encouraging Gene Therapy Results in Genetic Form of Blindness
Previous Claims of siRNA Therapeutic Effects Called into Question by Report in Human Gene Therapy
Human Gene Therapy has Launched "Instant Online” publication 72 hours after acceptance!
Gene Therapy Slows Progression of Fatal Neurodegenerative Disease in Children
Full-text of the current issue available FREE online.
Due to the dynamic nature of this field, the journal has a rapid online publication policy. All papers are published online within 3-4 weeks of acceptance, and will appear at a later date in the print journal.
Special feature papers in a recent issue
Five stimulating commentaries that discuss the key controversies related to patient recruitment and trial management. Editor-in-Chief, Dr. James Wilson comments. The issue also includes two review papers in a series describing the state-of-the-art and potential therapeutic applications of RNAi and microRNAs. Associate Editor, Dr. Mark Kay introduces the series.
New “Open Option” for Human Gene Therapy
Human Gene Therapy is the definitive peer-reviewed rapid-publication journal covering all aspects of human gene therapy. The Journal publishes scientific papers on original investigations into the transfer and expression of genes in mammals, including humans. Improvements in vector development, delivery systems, and animal models, particularly in the areas of cancer, heart disease, viral disease, genetic disease, and neurological disease, are covered.
Other key features include a continuously updated directory of human gene marker and gene therapy clinical protocols, as well as ethical/legal/regulatory papers related directly to the area of gene transfer into humans.
*Journal Citation Reports® 2008, published by Thomson Reuters
Subscribe
MEDLINE; Current Contents®/Life Sciences; EMBASE/Excerpta Medica; Science Citation Index Expanded; Science Citation Index®; BIOSIS Previews; Biotechnology Citation Index®; Biological Abstracts; EMBiology; Scopus